Health Dec 01 Maker of $1,000 hepatitis C pill was focused on profits, not patients, report finds By Ricardo Alonso-Zaldivar, Associated Press
Health Jun 24 California caps what patients pay for pricey drugs. Will other states follow? Expensive specialty medicines used to treat cancer and chronic illnesses have forced some very ill Americans to choose between getting proper treatment and paying their rent. To ease the financial burden, the California agency that governs the state’s Affordable Care… By April Dembosky, KQED
Health Jun 17 Insurers choke on price of new hepatitis C-curing pill WASHINGTON — Your money or your life? Sovaldi, a new pill for hepatitis C, cures the liver-wasting disease in 9 of 10 patients, but treatment can cost more than $90,000. Leading medical societies recommend the drug as a first-line treatment,… By Ricardo Alonso-Zaldivar, Associated Press